Extracellular Matrix Pharmacology Congress 2024
jún. 17., H
|København
The goal of ECM 2024 is to improve our understanding of the extracelullar matrix across different diseases. The program will include internationally renowned ECM researchers and industry experts from different disease areas: liver, lung, kidney, cardiovascular etc.
Time & Location
2024. jún. 17. 9:00 – 2024. jún. 19. 6:00
København, Arni Magnussons Gade 2, 1577 København, Denmark
About the event
Honored to present our research on the anti-fibrotic effect of Sigma-1 receptor agonists at the Extracellular Matrix Pharmacology Congress 2024! Idiopathic Pulmonary Fibrosis (IPF) is a progressive lung disease where the tissue in the lungs becomes thickened and scarred over time, leading to functional decline and ultimately respiratory failure. Unfortunately, there is no cure for IPF, current treatment aims to relieve symptoms and slow the progression of the disease.
Our findings reveal the potential of Sigma-1 receptor agonists in combating pulmonary fibrosis, offering hope for improved treatment strategies in the future. We are grateful for the opportunity to share our work with fellow researchers and experts in the field. Looking forward to further collaborations and advancing our understanding of respiratory health.